ID

41855

Description

Disclaimer: Der „GECCO - German Corona Consensus - Covid-19 Research-Dataset“ Inhalt, der auf dem Portal für medizinische Datenmodelle (MDM Portal) zu finden ist, ersetzt nicht den GECCO Datensatz auf simplifier.net. Für die Nutzung von GECCO-FHIR-Profilen verwenden Sie bitte die auf https://simplifier.net/ForschungsnetzCovid-19/ verfügbaren Profile. Der FHIR-Download auf MDM erzeugt lediglich eine FHIR-Fragebogenresource. This version of the GECCO logical model is based on https://art-decor.org/art-decor/decor-datasets--covid19f- on the "final" version published mid to end September 2020. For actual use of FHIR profiles, please use the profiles available on https://simplifier.net/ForschungsnetzCovid-19/ResearchDatasetGECCO/~overview (FHIR download on MDM is only a FHIR questionnaire resource). A few items implicated by comments/descriptions of items on art-decor have been added: "Datum der letzten Impfung" (date of last vaccination for all listed vaccinations), "Schweregrad" (Severity of Kidney Diseases), "Ort" (Location of vacation in the last 14 days), "Befund bildgebender Verfahren im Rahmen von COVID-19" added separately for all types of imaging procedures listed, "Symptom Schweregrad" (Severity of Symptoms) for each symptom listed, and an "NCT-/EudraCT-Nummer" item for Study participation. Official German text from http://cocos.team/datasets.html: Zur Bewältigung der aktuellen Pandemie und der damit einhergehenden Behandlung von Patienten fördert das Bundesministerium für Bildung und Forschung (BMBF) ein nationales Netzwerk der Universitätsmedizin im Kampf gegen COVID-19. Unter anderem soll das Netzwerk die Daten der behandelten COVID-19 Patienten systematisch erfassen und bündeln. Die Forschenden sollen die Behandlung der COVID-19-Patienten standardisiert erheben, verfolgen und analysieren. Die hohe Bedrohungslage hat zu intensiver wissenschaftlicher Aktivität zu COVID-19 geführt, wozu zahlreiche regionale, nationale und internationale epidemiologische Erhebungen und Registerstudien zählen. Der Konsensusdatensatz gibt der Wissenschaft um COVID-19 eine gemeinsame Sprache und Arbeitsgrundlage. Inofficial translation: In order to cope with the current pandemic and the associated treatment of patients, the Federal Ministry of Education and Research (BMBF) is funding a national network of university medicine in the fight against COVID-19. Among other things, the network will systematically collect and bundle the data of the treated COVID-19 patients. The researchers are to collect, track and analyze the treatment of COVID-19 patients in a standardized way. The high threat level has led to intensive scientific activity on COVID-19, including numerous regional, national and international epidemiological surveys and register studies. The consensus data set provides a common language and working basis for the science around COVID-19. Not yet integrated: Items for "Data Absent Reason", "Certainty of Presence", "Uncertainty of Presence", and "Certainty of absence"; "therapeutic intention", "Medication Statement Status", "EventStatus"; longer versions of the ValueSets published separately from the variables in art-decor.

Link

https://simplifier.net/ForschungsnetzCovid-19/

Keywords

  1. 9/29/20 9/29/20 - Sarah Riepenhausen
  2. 9/29/20 9/29/20 - Sarah Riepenhausen
  3. 10/9/20 10/9/20 -
  4. 10/28/20 10/28/20 -
  5. 1/13/21 1/13/21 - Sarah Riepenhausen
  6. 2/3/21 2/3/21 - Sarah Riepenhausen
  7. 2/3/21 2/3/21 - Sarah Riepenhausen
  8. 8/25/21 8/25/21 - Sarah Riepenhausen
  9. 9/2/21 9/2/21 - Sarah Riepenhausen
  10. 9/6/21 9/6/21 - Sarah Riepenhausen
  11. 1/5/23 1/5/23 - Sarah Riepenhausen
Copyright Holder

Nationales Forschungsnetzwerk der Universitätsmedizin zu Covid-19

Uploaded on

February 3, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

GECCO - German Corona Consensus - Covid-19 Research-Dataset

Medikation

Medikation
Description

Medikation

Alias
UMLS CUI-1
C0013227
Medikamentöse Therapie bei Covid-19 Erkrankung Antipyretika
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0003419
1.2.276.0.76.5.498
N02B
2.25.24197857203266734864793317670504947440
Antipyretic
Medikamentöse Therapie bei Covid-19 Erkrankung Kortikosteroide
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0001617
SNOMED CT[1]
768759001
1.2.276.0.76.5.498[1]
G01B
1.2.276.0.76.5.498[2]
H02
1.2.276.0.76.5.498[3]
M01BA
1.2.276.0.76.5.498[4]
R03AL
1.2.276.0.76.5.498[5]
S02B
1.2.276.0.76.5.498[6]
R03AK
Medikamentöse Therapie bei Covid-19 Erkrankung Atazanavir
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C1145759
SNOMED CT[1]
413591007
1.2.276.0.76.5.498[1]
J05AE08
1.2.276.0.76.5.498[2]
J05AR15
1.2.276.0.76.5.498[3]
J05AR23
Medikamentöse Therapie bei Covid-19 Erkrankung Darunavir
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C1435444
SNOMED CT[1]
424096001
1.2.276.0.76.5.498[1]
J05AR22
1.2.276.0.76.5.498[2]
J05AE10
1.2.276.0.76.5.498[3]
J05AR14
Medikamentöse Therapie bei Covid-19 Erkrankung Chloroquine phosphate
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0055447
SNOMED CT[1]
14728000
1.2.276.0.76.5.498
P01BA01
Medikamentöse Therapie bei Covid-19 Erkrankung Hydroxychloroquine
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0020336
SNOMED CT[1]
83490000
1.2.276.0.76.5.498
P01BA02
Medikamentöse Therapie bei Covid-19 Erkrankung Ivermectin
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0022322
SNOMED CT[1]
96138006
1.2.276.0.76.5.498[1]
D11AX22
1.2.276.0.76.5.498[2]
P02CF01
Medikamentöse Therapie bei Covid-19 Erkrankung Lopinavir/ritonavir
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0674432
UMLS CUI [3]
C0292818
SNOMED CT[1]
134573001
1.2.276.0.76.5.498
J05AR10
Medikamentöse Therapie bei Covid-19 Erkrankung Ganciclovir
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0017066
SNOMED CT[1]
78025001
1.2.276.0.76.5.498[1]
J05AB06
1.2.276.0.76.5.498[2]
S01AD09
Medikamentöse Therapie bei Covid-19 Erkrankung Oseltamivir
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0874161
SNOMED CT[1]
386142008
1.2.276.0.76.5.498
J05AH02
Medikamentöse Therapie bei Covid-19 Erkrankung Remdesivir
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C4726677
The Unique Ingredient Identifier (UNII) generated from the FDA Substance Registration System (SRS).
3QKI37EEHE
Medikamentöse Therapie bei Covid-19 Erkrankung Ribavirin
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0035525
SNOMED CT[1]
35063004
1.2.276.0.76.5.498
J05AP01
Medikamentöse Therapie bei Covid-19 Erkrankung Camostat
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0129975
1.2.276.0.76.5.498
B02AB04
Medikamentöse Therapie bei Covid-19 Erkrankung Favipiravir
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C1138226
1.2.276.0.76.5.498
J05AX27
Medikamentöse Therapie bei Covid-19 Erkrankung Convalescent plasma
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2,1]
C0032105
UMLS CUI [2,2]
C0740326
2.16.840.1.113883.6.18.2.6[1]
E9743
2.16.840.1.113883.6.18.2.6[2]
E9744
2.16.840.1.113883.6.18.2.6[3]
E9745
2.16.840.1.113883.6.18.2.6[4]
E9746
2.16.840.1.113883.6.18.2.6[5]
E9747
2.16.840.1.113883.6.18.2.6[6]
E9748
2.16.840.1.113883.6.18.2.6[7]
E9749
2.16.840.1.113883.6.18.2.6[8]
E9750
2.16.840.1.113883.6.18.2.6[9]
E9752
2.25.24197857203266734864793317670504947440
Convalescent-plasma
Medikamentöse Therapie bei Covid-19 Erkrankung Steroids (> 0.5 mg/kg prednisone equivalents)
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2,1]
C0038317
UMLS CUI [2,2]
C0178602
2.25.24197857203266734864793317670504947440
Steroids-gt
Medikamentöse Therapie bei Covid-19 Erkrankung Steroids (<= 0.5 mg/kg prednisone equivalents)
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2,1]
C0445550
UMLS CUI [2,2]
C0038317
UMLS CUI [2,3]
C0178602
2.25.24197857203266734864793317670504947440
Steroids-st
Medikamentöse Therapie bei Covid-19 Erkrankung Tocilizumab
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C1609165
SNOMED CT[1]
444649004
1.2.276.0.76.5.487[1]
6-005.m
1.2.276.0.76.5.487[2]
6-005.n
1.2.276.0.76.5.498
L04AC07
Medikamentöse Therapie bei Covid-19 Erkrankung Sarilumab
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C3885145
SNOMED CT[1]
763522001
1.2.276.0.76.5.487
6-00a.g
1.2.276.0.76.5.499
L04AC14
Medikamentöse Therapie bei Covid-19 Erkrankung CNI or mTor inhibitors (e.g. cyclosporin A, tacrolimus, sirolimus, everolimus)
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C1562036
UMLS CUI [3]
C2746052
UMLS CUI [4]
C0010592
UMLS CUI [5]
C0085149
UMLS CUI [6]
C0072980
UMLS CUI [7]
C0541315
SNOMED CT[1]
416587008
1.2.276.0.76.5.487[1]
6-005.8
1.2.276.0.76.5.487[2]
6-004.e
1.2.276.0.76.5.498[1]
L01XE10
1.2.276.0.76.5.498[2]
L04AA18
1.2.276.0.76.5.498[3]
L04AA10
1.2.276.0.76.5.498[4]
S01XA18
1.2.276.0.76.5.498[5]
L01XE18
1.2.276.0.76.5.498[6]
D11AH01
1.2.276.0.76.5.498[7]
L04AB
1.2.276.0.76.5.498[8]
L04AD
Medikamentöse Therapie bei Covid-19 Erkrankung Anti-TNF-alpha inhibitors (e.g. adalimumab, etanercept)
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C3653350
UMLS CUI [3]
C1122087
UMLS CUI [4]
C0717758
SNOMED CT[1]
416897008
1.2.276.0.76.5.487[1]
6-001.d
1.2.276.0.76.5.487[2]
6-002.b
1.2.276.0.76.5.487[3]
6-005.7
1.2.276.0.76.5.487[4]
6-005.2
1.2.276.0.76.5.487[5]
6-001.e
Medikamentöse Therapie bei Covid-19 Erkrankung Il1-receptor antangonists
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C2917260
SNOMED CT[1]
430817009
1.2.276.0.76.5.487
6-006.7
1.2.276.0.76.5.498
L04AC
Medikamentöse Therapie bei Covid-19 Erkrankung Ruxolitinib
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C2931926
SNOMED CT[1]
703779004
1.2.276.0.76.5.487
6-009.4
Medikamentöse Therapie bei Covid-19 Erkrankung Colchicine
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0009262
SNOMED CT[1]
73133000
1.2.276.0.76.5.498
M04AC01
Medikamentöse Therapie bei Covid-19 Erkrankung Interferone (any)
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0021747
SNOMED CT[1]
768865007
1.2.276.0.76.5.498
S01AD05
Medikamentöse Therapie bei Covid-19 Erkrankung 25-Hydroxyvitamin D
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0535968
SNOMED CT[1]
88519001
1.2.276.0.76.5.498
A11CC06
Medikamentöse Therapie bei Covid-19 Erkrankung Zinc
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [2]
C0043481
SNOMED CT[1]
4877006
1.2.276.0.76.5.498
A12CB76
Medikamentöse Therapie bei Covid-19 Erkrankung Andere
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205394
ACE-Hemmer
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

text

Alias
UMLS CUI [1]
C0003015
SNOMED CT[1]
41549009
Immunglobuline
Description

Kommentar: FHIR-Mapping: MedicationStatement Versionsdatum: 2020-04-08

Data type

text

Alias
UMLS CUI [1]
C0021027
SNOMED CT[1]
333710000
Medikamentöse Therapie mit Antikoagulantien Unfraktioniertes Heparin
Description

Kommentar: FHIR-Mapping: MedicationStatement Operationalisierung: Absicht (Warum wurde das Medikament eingenommen)?: prophylaktisch oder therapeutisch Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1]
C0003281
UMLS CUI [2]
C2825026
SNOMED CT[1]
81839001
1.2.276.0.76.5.498[1]
B01AB01
1.2.276.0.76.5.498[2]
B01AB51
Medikamentöse Therapie mit Antikoagulantien Niedermolekulares Heparin
Description

Kommentar: FHIR-Mapping: MedicationStatement Operationalisierung: Absicht (Warum wurde das Medikament eingenommen)?: prophylaktisch oder therapeutisch Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1]
C0003281
UMLS CUI [2]
C0019139
SNOMED CT[1]
81839001
1.2.276.0.76.5.498[1]
B01AB08
1.2.276.0.76.5.498[2]
B01AB13
1.2.276.0.76.5.498[3]
B01AB04
1.2.276.0.76.5.498[4]
B01AB05
1.2.276.0.76.5.498[5]
B01AB06
1.2.276.0.76.5.498[6]
B01AB10
1.2.276.0.76.5.498[7]
B01AB12
1.2.276.0.76.5.498[8]
B01AB63
1.2.276.0.76.5.498[9]
B01AB07
1.2.276.0.76.5.498[10]
B01AB11
Medikamentöse Therapie mit Antikoagulantien Argatroban
Description

Kommentar: FHIR-Mapping: MedicationStatement Operationalisierung: Absicht (Warum wurde das Medikament eingenommen)?: prophylaktisch oder therapeutisch Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1]
C0003281
UMLS CUI [2]
C0048470
SNOMED CT[1]
81839001
1.2.276.0.76.5.498
B01AE03
Medikamentöse Therapie mit Antikoagulantien Plättchenaggregationshemmer
Description

Kommentar: FHIR-Mapping: MedicationStatement Operationalisierung: Absicht (Warum wurde das Medikament eingenommen)?: prophylaktisch oder therapeutisch Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1]
C0003281
UMLS CUI [2]
C0032177
SNOMED CT[1]
81839001
1.2.276.0.76.5.498
B01AC
Medikamentöse Therapie mit Antikoagulantien Danaparoid
Description

Kommentar: FHIR-Mapping: MedicationStatement Operationalisierung: Absicht (Warum wurde das Medikament eingenommen)?: prophylaktisch oder therapeutisch Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1]
C0003281
UMLS CUI [2]
C0259507
SNOMED CT[1]
81839001
1.2.276.0.76.5.498
B01AB09
Medikamentöse Therapie mit Antikoagulantien Phenprocoumon
Description

Kommentar: FHIR-Mapping: MedicationStatement Operationalisierung: Absicht (Warum wurde das Medikament eingenommen)?: prophylaktisch oder therapeutisch Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1]
C0003281
UMLS CUI [2]
C0031444
SNOMED CT[1]
81839001
1.2.276.0.76.5.498
B01AA04
Medikamentöse Therapie mit Antikoagulantien DOAK
Description

Kommentar: FHIR-Mapping: MedicationStatement Operationalisierung: Absicht (Warum wurde das Medikament eingenommen)?: prophylaktisch oder therapeutisch Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1]
C0003281
UMLS CUI [2,1]
C0360593
UMLS CUI [2,2]
C0442027
SNOMED CT[1]
81839001
1.2.276.0.76.5.498[1]
B01AF
1.2.276.0.76.5.498[2]
B01AE
Medikamentöse Therapie mit Antikoagulantien Sonstige
Description

Kommentar: FHIR-Mapping: MedicationStatement Operationalisierung: Absicht (Warum wurde das Medikament eingenommen)?: prophylaktisch oder therapeutisch Versionsdatum: 2020-04-08

Data type

boolean

Alias
UMLS CUI [1,1]
C0003281
UMLS CUI [1,2]
C0205394
SNOMED CT[1]
81839001

Similar models

Medikation

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Medikation
C0013227 (UMLS CUI-1)
Covid-19-Therapie: Antipyretika
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Antipyretika
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0003419 (UMLS CUI [2])
N02B (1.2.276.0.76.5.498)
Antipyretic (2.25.24197857203266734864793317670504947440)
Covid-19-Therapie: Kortikosteroide
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Kortikosteroide
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2])
768759001 (SNOMED CT[1])
G01B (1.2.276.0.76.5.498[1])
H02 (1.2.276.0.76.5.498[2])
M01BA (1.2.276.0.76.5.498[3])
R03AL (1.2.276.0.76.5.498[4])
S02B (1.2.276.0.76.5.498[5])
R03AK (1.2.276.0.76.5.498[6])
Covid-19-Therapie: Atazanavir
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Atazanavir
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C1145759 (UMLS CUI [2])
413591007 (SNOMED CT[1])
J05AE08 (1.2.276.0.76.5.498[1])
J05AR15 (1.2.276.0.76.5.498[2])
J05AR23 (1.2.276.0.76.5.498[3])
Covid-19-Therapie: Darunavir
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Darunavir
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C1435444 (UMLS CUI [2])
424096001 (SNOMED CT[1])
J05AR22 (1.2.276.0.76.5.498[1])
J05AE10 (1.2.276.0.76.5.498[2])
J05AR14 (1.2.276.0.76.5.498[3])
Covid-19-Therapie: Chloroquine phosphate
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Chloroquine phosphate
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0055447 (UMLS CUI [2])
14728000 (SNOMED CT[1])
P01BA01 (1.2.276.0.76.5.498)
Covid-19-Therapie: Hydroxychloroquine
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Hydroxychloroquine
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0020336 (UMLS CUI [2])
83490000 (SNOMED CT[1])
P01BA02 (1.2.276.0.76.5.498)
Covid-19-Therapie: Ivermectin
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Ivermectin
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0022322 (UMLS CUI [2])
96138006 (SNOMED CT[1])
D11AX22 (1.2.276.0.76.5.498[1])
P02CF01 (1.2.276.0.76.5.498[2])
Covid-19-Therapie: Lopinavir/ritonavir
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Lopinavir/ritonavir
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0674432 (UMLS CUI [2])
C0292818 (UMLS CUI [3])
134573001 (SNOMED CT[1])
J05AR10 (1.2.276.0.76.5.498)
Covid-19-Therapie: Ganciclovir
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Ganciclovir
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0017066 (UMLS CUI [2])
78025001 (SNOMED CT[1])
J05AB06 (1.2.276.0.76.5.498[1])
S01AD09 (1.2.276.0.76.5.498[2])
Covid-19-Therapie: Oseltamivir
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Oseltamivir
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0874161 (UMLS CUI [2])
386142008 (SNOMED CT[1])
J05AH02 (1.2.276.0.76.5.498)
Covid-19-Therapie: Remdesivir
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Remdesivir
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C4726677 (UMLS CUI [2])
3QKI37EEHE (The Unique Ingredient Identifier (UNII) generated from the FDA Substance Registration System (SRS).)
Covid-19-Therapie: Ribavirin
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Ribavirin
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0035525 (UMLS CUI [2])
35063004 (SNOMED CT[1])
J05AP01 (1.2.276.0.76.5.498)
Covid-19-Therapie: Camostat
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Camostat
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0129975 (UMLS CUI [2])
B02AB04 (1.2.276.0.76.5.498)
Covid-19-Therapie: Favipiravir
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Favipiravir
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C1138226 (UMLS CUI [2])
J05AX27 (1.2.276.0.76.5.498)
Covid-19-Therapie: Convalescent plasma
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Convalescent plasma
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0032105 (UMLS CUI [2,1])
C0740326 (UMLS CUI [2,2])
E9743 (2.16.840.1.113883.6.18.2.6[1])
E9744 (2.16.840.1.113883.6.18.2.6[2])
E9745 (2.16.840.1.113883.6.18.2.6[3])
E9746 (2.16.840.1.113883.6.18.2.6[4])
E9747 (2.16.840.1.113883.6.18.2.6[5])
E9748 (2.16.840.1.113883.6.18.2.6[6])
E9749 (2.16.840.1.113883.6.18.2.6[7])
E9750 (2.16.840.1.113883.6.18.2.6[8])
E9752 (2.16.840.1.113883.6.18.2.6[9])
Convalescent-plasma (2.25.24197857203266734864793317670504947440)
Covid-19-Therapie: Steroids (> 0.5 mg/kg prednisone equivalents)
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Steroids (> 0.5 mg/kg prednisone equivalents)
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0038317 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
Steroids-gt (2.25.24197857203266734864793317670504947440)
Covid-19-Therapie: Steroids (<= 0.5 mg/kg prednisone equivalents)
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Steroids (<= 0.5 mg/kg prednisone equivalents)
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0445550 (UMLS CUI [2,1])
C0038317 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
Steroids-st (2.25.24197857203266734864793317670504947440)
Covid-19-Therapie: Tocilizumab
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Tocilizumab
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C1609165 (UMLS CUI [2])
444649004 (SNOMED CT[1])
6-005.m (1.2.276.0.76.5.487[1])
6-005.n (1.2.276.0.76.5.487[2])
L04AC07 (1.2.276.0.76.5.498)
Covid-19-Therapie: Sarilumab
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Sarilumab
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C3885145 (UMLS CUI [2])
763522001 (SNOMED CT[1])
6-00a.g (1.2.276.0.76.5.487)
L04AC14 (1.2.276.0.76.5.499)
Covid-19-Therapie: CNI or mTor inhibitors (e.g. cyclosporin A, tacrolimus, sirolimus, everolimus)
Item
Medikamentöse Therapie bei Covid-19 Erkrankung CNI or mTor inhibitors (e.g. cyclosporin A, tacrolimus, sirolimus, everolimus)
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C1562036 (UMLS CUI [2])
C2746052 (UMLS CUI [3])
C0010592 (UMLS CUI [4])
C0085149 (UMLS CUI [5])
C0072980 (UMLS CUI [6])
C0541315 (UMLS CUI [7])
416587008 (SNOMED CT[1])
6-005.8 (1.2.276.0.76.5.487[1])
6-004.e (1.2.276.0.76.5.487[2])
L01XE10 (1.2.276.0.76.5.498[1])
L04AA18 (1.2.276.0.76.5.498[2])
L04AA10 (1.2.276.0.76.5.498[3])
S01XA18 (1.2.276.0.76.5.498[4])
L01XE18 (1.2.276.0.76.5.498[5])
D11AH01 (1.2.276.0.76.5.498[6])
L04AB (1.2.276.0.76.5.498[7])
L04AD (1.2.276.0.76.5.498[8])
Covid-19-Therapie: Anti-TNF-alpha inhibitors (e.g. adalimumab, etanercept)
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Anti-TNF-alpha inhibitors (e.g. adalimumab, etanercept)
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C3653350 (UMLS CUI [2])
C1122087 (UMLS CUI [3])
C0717758 (UMLS CUI [4])
416897008 (SNOMED CT[1])
6-001.d (1.2.276.0.76.5.487[1])
6-002.b (1.2.276.0.76.5.487[2])
6-005.7 (1.2.276.0.76.5.487[3])
6-005.2 (1.2.276.0.76.5.487[4])
6-001.e (1.2.276.0.76.5.487[5])
Covid-19-Therapie: Il1-receptor antangonists
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Il1-receptor antangonists
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2917260 (UMLS CUI [2])
430817009 (SNOMED CT[1])
6-006.7 (1.2.276.0.76.5.487)
L04AC (1.2.276.0.76.5.498)
Covid-19-Therapie: Ruxolitinib
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Ruxolitinib
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2931926 (UMLS CUI [2])
703779004 (SNOMED CT[1])
6-009.4 (1.2.276.0.76.5.487)
Covid-19-Therapie: Colchicine
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Colchicine
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0009262 (UMLS CUI [2])
73133000 (SNOMED CT[1])
M04AC01 (1.2.276.0.76.5.498)
Covid-19-Therapie: Interferone (any)
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Interferone (any)
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0021747 (UMLS CUI [2])
768865007 (SNOMED CT[1])
S01AD05 (1.2.276.0.76.5.498)
Covid-19-Therapie: 25-Hydroxyvitamin D
Item
Medikamentöse Therapie bei Covid-19 Erkrankung 25-Hydroxyvitamin D
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0535968 (UMLS CUI [2])
88519001 (SNOMED CT[1])
A11CC06 (1.2.276.0.76.5.498)
Covid-19-Therapie: Zinc
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Zinc
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0043481 (UMLS CUI [2])
4877006 (SNOMED CT[1])
A12CB76 (1.2.276.0.76.5.498)
Covid-19-Therapie: Andere
Item
Medikamentöse Therapie bei Covid-19 Erkrankung Andere
boolean
C5203670 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Item
ACE-Hemmer
text
C0003015 (UMLS CUI [1])
41549009 (SNOMED CT[1])
Code List
ACE-Hemmer
CL Item
ja (ja)
active (2.16.840.1.113883.4.642.4.1379)
C1705108 (UMLS CUI-1)
(Comment:de)
CL Item
nein (nein)
not-taken (2.16.840.1.113883.4.642.4.1379)
C1298908 (UMLS CUI-1)
(Comment:de)
CL Item
unbekannt (unbekannt)
Unknown (2.16.840.1.113883.4.642.4.1048)
Unknown (2.16.840.1.113883.4.642.4.1379)
C0439673 (UMLS CUI-1)
(Comment:de)
CL Item
abgebrochen (abgebrochen)
stopped (2.16.840.1.113883.4.642.4.1379)
C0520253 (UMLS CUI-1)
(Comment:de)
Item
Immunglobuline
text
C0021027 (UMLS CUI [1])
333710000 (SNOMED CT[1])
Code List
Immunglobuline
CL Item
ja (ja)
active (2.16.840.1.113883.4.642.4.1379)
C1705108 (UMLS CUI-1)
(Comment:de)
CL Item
nein (nein)
not-taken (2.16.840.1.113883.4.642.4.1379)
C1298908 (UMLS CUI-1)
(Comment:de)
CL Item
unbekannt (unbekannt)
Unknown (2.16.840.1.113883.4.642.4.1048)
Unknown (2.16.840.1.113883.4.642.4.1379)
C0439673 (UMLS CUI-1)
(Comment:de)
Antikoagulation: Unfraktioniertes Heparin
Item
Medikamentöse Therapie mit Antikoagulantien Unfraktioniertes Heparin
boolean
C0003281 (UMLS CUI [1])
C2825026 (UMLS CUI [2])
81839001 (SNOMED CT[1])
B01AB01 (1.2.276.0.76.5.498[1])
B01AB51 (1.2.276.0.76.5.498[2])
Antikoagulation: Niedermolekulares Heparin
Item
Medikamentöse Therapie mit Antikoagulantien Niedermolekulares Heparin
boolean
C0003281 (UMLS CUI [1])
C0019139 (UMLS CUI [2])
81839001 (SNOMED CT[1])
B01AB08 (1.2.276.0.76.5.498[1])
B01AB13 (1.2.276.0.76.5.498[2])
B01AB04 (1.2.276.0.76.5.498[3])
B01AB05 (1.2.276.0.76.5.498[4])
B01AB06 (1.2.276.0.76.5.498[5])
B01AB10 (1.2.276.0.76.5.498[6])
B01AB12 (1.2.276.0.76.5.498[7])
B01AB63 (1.2.276.0.76.5.498[8])
B01AB07 (1.2.276.0.76.5.498[9])
B01AB11 (1.2.276.0.76.5.498[10])
Antikoagulation: Argatroban
Item
Medikamentöse Therapie mit Antikoagulantien Argatroban
boolean
C0003281 (UMLS CUI [1])
C0048470 (UMLS CUI [2])
81839001 (SNOMED CT[1])
B01AE03 (1.2.276.0.76.5.498)
Antikoagulation: Plättchenaggregationshemmer
Item
Medikamentöse Therapie mit Antikoagulantien Plättchenaggregationshemmer
boolean
C0003281 (UMLS CUI [1])
C0032177 (UMLS CUI [2])
81839001 (SNOMED CT[1])
B01AC (1.2.276.0.76.5.498)
Antikoagulation: Danaparoid
Item
Medikamentöse Therapie mit Antikoagulantien Danaparoid
boolean
C0003281 (UMLS CUI [1])
C0259507 (UMLS CUI [2])
81839001 (SNOMED CT[1])
B01AB09 (1.2.276.0.76.5.498)
Antikoagulation: Phenprocoumon
Item
Medikamentöse Therapie mit Antikoagulantien Phenprocoumon
boolean
C0003281 (UMLS CUI [1])
C0031444 (UMLS CUI [2])
81839001 (SNOMED CT[1])
B01AA04 (1.2.276.0.76.5.498)
Antikoagulation: DOAK
Item
Medikamentöse Therapie mit Antikoagulantien DOAK
boolean
C0003281 (UMLS CUI [1])
C0360593 (UMLS CUI [2,1])
C0442027 (UMLS CUI [2,2])
81839001 (SNOMED CT[1])
B01AF (1.2.276.0.76.5.498[1])
B01AE (1.2.276.0.76.5.498[2])
Antikoagulation: Sonstige
Item
Medikamentöse Therapie mit Antikoagulantien Sonstige
boolean
C0003281 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
81839001 (SNOMED CT[1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial